Before broad endorsement, we need India-specific real-world evidence
That said, not everyone in Casper will be suitable for tirzepatide treatment
Your treatment plan may include: Medical evaluation and assessment Prescription weight loss medications GLP-1 therapy Nutrition counseling Behavioral and lifestyle support Exercise recommendations Ongoing progress monitoring Our goal is to help patients lose weight safely while improving overall health, energy, and quality of life
EPS: ~$23.50 Forward P/E: ~42 (premium justified by growth) PEG Ratio: ~0.9 (attractive given growth rate) Long-Term Track Record Performance: 52-Week Range: $623.78 - $999.92 1-Year Return: +20-25% (volatile but trending up) Market Leadership: Approaching $1 trillion valuation Dividend Profile: Current Yield: ~0.6% (modest but growing) Annual Dividend: $6.00 per share Growth Rate: Consistently increasing ~15% CAGR The dividend is small now, but management prioritizes reinvestment in R&D while rewarding long-term shareholders with steady increases
In fact, some studies found that semaglutide (GLP-1 RA) medications helped people lose an average of 9%-17% of their body weight in a little over a year
Express Scripts vs Cigna Evernorth: the 2024 merger and what changed In December 2023, Cigna completed its acquisition of Express Scripts' parent company, merging Express Scripts with Cigna's existing pharmacy benefit manager, Evernorth